OpenEvidence
Coverage of OpenEvidence in the Nexus archive.
- STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
A study in Nature Medicine compared clinical AI systems OpenEvidence and UpToDate Expert AI against general LLMs, sparking debate in the clinical AI community. The article discusses challenges in benchmarking these systems, emphasizing that headline-driven summaries often oversimplify complex results.
- STAT+: Clinical chatbots are taking medicine by storm. Should doctors trust them?
Clinical large language models developed by companies like OpenEvidence, Doximity, and UpToDate are widely used by U.S. doctors, but a June 2024 study in Nature Medicine found these models performed worse than generalist AI models on clinical questions. The findings sparked significant debate within the health AI community, with some interpreting the results as a 'clear victory for general frontier models.'
- OpenEvidence is bribing spouses of CMI and Genentech leadership
OpenEvidence is accused of bribing spouses of leadership at CMI and Genentech to block competitors. The claim appears in a news article with no comments and three upvotes.
- STAT+: A sweeping new AI to detect heart conditions is coming to OpenEvidence
EchoNext, an AI model developed by New York-Presbyterian Hospital researchers and commercialized by Pathway Labs, has received FDA clearance to detect seven forms of structural heart disease from EKGs. Pathway Labs will license the technology to OpenEvidence, a medical evidence search engine used by hundreds of thousands of clinicians.
- STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’
OpenEvidence has built a free chatbot for doctors and achieved a $12 billion valuation in four years, with about 650,000 U.S. physicians using it actively. The company is now facing competitive pressures and questions about its ad-based business model. OpenEvidence is aiming to expand its reach to hospitals.
- STAT+: Dexcom CEO hints at future uses for CGM
Dexcom CEO hints at future uses for CGM, and the author is attending the STAT Breakthrough Summit West in San Francisco. The summit features interviews with key figures like OpenEvidence CTO Zachary Ziegler. Readers can follow coverage on Statnews.com and social channels.
- Most U.S. doctors are quietly using this AI tool. Few patients know about it.
Most U.S. doctors are using OpenEvidence, an AI tool, to inform their medical decision-making, with few patients aware of its use. This tool is being utilized by a significant majority of doctors in the U.S. The use of OpenEvidence is intended to support medical decisions.
- STAT+: Did AI really beat doctors at diagnosis?
The article discusses the STAT Health Tech newsletter and its upcoming Breakthrough Summit West in San Francisco, featuring an interview with OpenEvidence co-founder Zachary Ziegler. The summit will explore how technology is transforming life sciences. Registration is still open.